|
The
Advanced Products Group is responsible for the development
of the Company's major proprietary biomedical diagnostics
products. These proprietary products are protected under issued,
allowed and/or filed US and international patents that are owned
by or have been licensed by ABTECH Scientific, Inc.
As
part of its emerging growth strategy, ABTECH has targeted the
near patient biomedical diagnostics market. The company's
proprietary biosensor and biochip technologies are currently
being developed to reflect this strategy with products for
clinical molecular diagnostics, chemical toxcicity testing,
breath analysis and monitoring, and tumor staging for cancer
diagnostics.
Proprietary
products of the group include:
BioSenSysTM,
a Multianalyte Diagnostics Workstation. BioSenSys performs
biosensor-based immunodiagnostic assays for the monitoring of
blood metabolites, therapeutic drugs, and microbiological
agents.
ToxSenTM,
a Chemical Toxicity Sensor. Based on a multi-element array of
differentiated whole cells, ToxSen comprises a quantitative
screening test along with associated methods and apparatus for
performing rapid, on-site screening of the chemical toxicity of
water, wastewater and other effluent streams.
EnVOCSysTM,
a VOC System for the monitoring of volatile organic constituents
of the expired breath. The system comprises a 16-element array
sensor (EnVOCSenTM) that is responsive to gas
phase constituents at the sub-ppm level.
beChipTM,
the Bioelectronic Biochip is a 64-element impedimetic array for
bioelectronic detection of DNA hybridization. This OncoChipTM
is targeted at clinical cancer diagnostics and the rapid genomic
staging of malignancies and as a complement to histopathology.
Request
additional product information from Customer
Service.
View
a list of recent Technical
Publications.
|